Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Thomas Eleveld

Thomas Eleveld

Postdoc

Looijenga groep

Telefoon 088 97 25 614

E-mail t.f.eleveld@prinsesmaximacentrum.nl

Translation research on testicular germ cell tumors.
- jun. 2023
- Thomas, Eleveld, et al
- Tijdschrift voor Urologie
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
- jan. 2023
- Thomas F, Eleveld, et al
- Frontiers in Oncology
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
- sep. 2022
- Kaylee M., Keller, et al
- Frontiers in Oncology
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
- apr. 2022
- Dennis M, Timmerman, et al
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Engineering large-scale chromosomal deletions by CRISPR-Cas9
- dec. 2021
- Thomas F, Eleveld, et al
- Nucleic acids research

Bekijk alle publicaties

Thomas Eleveld

Publicaties

Translation research on testicular germ cell tumors.

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

Engineering large-scale chromosomal deletions by CRISPR-Cas9